Metraipolis › archive › dc_e8a095c62996

Elevated serum plasminogen activator inhibitor-1 is associated with seizure burden, drug resistance, and neuroinflammatory markers in pediatric epilepsy — Europe PMC PMID:42523897

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42523897
DOI
10.3389/fped.2026.1804857
License (as archived)
solo-consultazione
Archived
2026-10-18T07:16:34.905Z
SHA-256 of the archived text
7455d766ec15ff92b9f3cf39a9c92ba11ce99115b5fbf48c866f185acf714677
Stable URL of this page
https://metraipolis.com/documento/dc_e8a095c62996

How to cite

Elevated serum plasminogen activator inhibitor-1 is associated with seizure burden, drug resistance, and neuroinflammatory markers in pediatric epilepsy — Europe PMC PMID:42523897 — Europe PMC (en), https://europepmc.org/article/MED/42523897 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e8a095c62996 (Metraipolis archive dc_e8a095c62996, sha256 7455d766ec15ff92b9f3cf39a9c92ba11ce99115b5fbf48c866f185acf714677)
BibTeX
@misc{dce8a095c62996,
  title = {Elevated serum plasminogen activator inhibitor-1 is associated with seizure burden, drug resistance, and neuroinflammatory markers in pediatric epilepsy — Europe PMC PMID:42523897},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42523897},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e8a095c62996; sha256 7455d766ec15ff92b9f3cf39a9c92ba11ce99115b5fbf48c866f185acf714677},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42523897. Agents can read the archived copy with the MCP tool read_document.